261P Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact
| Autor: | Diaz-Guardamino, I. Echavarria, Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Gilarranz, Y. Jerez, Anton, F. Moreno, Saenz, J.Á. García, Massarrah, T., Ocaña, I., Cebollero, M., Garcia, A.I. Ballesteros, Sarmiento, U. Bohn, Gomez, H., Rivera, H. Fuentes, Lopez, B. Herrero, Polo, C., Bueno, O., Rahimi, P., Muiño, C. Bueno, Jimenez, M. Martin |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S324-S325 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|